| Similar Articles |
|---|
 |
The Motley Fool
March 2, 2005
Stephen D. Simpson |
CardioDynamics' Palpitations The small-cap medical device maker has a good device, but driving growth is a bit tougher. An investment in CardioDynamics will be an exercise in patience.   |
The Motley Fool
June 29, 2005
Stephen D. Simpson |
CardioDynamics Needs Growth, Stat! CardioDynamics no longer deserves the benefit of the doubt until it produces some growth. Long-suffering investors shouldn't expect the cavalry to be arriving anytime soon. |
The Motley Fool
April 7, 2005
Stephen D. Simpson |
CardioDynamics' Code Blue Investing in small-cap medical technology requires patience, but CardioDynamics is starting to push its luck. |
The Motley Fool
December 16, 2004
Rich Duprey |
A Big Beat for CardioDynamics The medical device maker receives FDA clearance for new heart monitoring technology. Will management be able to push BioZ across the chasm, or will investors continue to suffer palpitations with each passing quarter? |
The Motley Fool
January 22, 2007
Dan Caplinger |
Understanding Medicare: Claims In general, Medicare provides a level of coverage that is fairly similar to what private health insurance plans offer. Here are some tips for getting the most from it. |
The Motley Fool
March 23, 2004
David Forrest |
Play Detective With Your Stocks Be ready to ask the important questions. Whenever one of your companies reports new fundamental information, it's time to get out your magnifying glass and prepare to ask tough questions. The answers will make the difference between your success or failure as an investor. |
